Römmele C, Brueckner J, Messmann H, Gölder S K
Department of Gastroenterology, Klinikum Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.
Gastroenterol Res Pract. 2016;2016:9657053. doi: 10.1155/2016/9657053. Epub 2016 Jan 6.
Background. In patients with known or suspected risk factors for gastrointestinal stenosis, the PillCam patency capsule (PC) is given before a video capsule endoscopy (VCE) in order to minimize the risk of capsule retention (CR). CR is considered unlikely upon excretion of the PC within 30 hours, excretion in an undamaged state after 30 hours, or radiological projection to the colon. Methods. We performed a retrospective analysis of 38 patients with risk factors for CR, who received a PC from 02/2013 to 04/2015 at Klinikum Augsburg. Results. Sixteen of our 38 patients observed a natural excretion after a mean time of 34 hours past ingestion. However, only 8 patients observed excretion within 30 hours, as recommended by the company. In 20 patients passage of the PC into the colon was shown via RFID-scan or radiological imaging (after 33 and 45 hours, resp.). Only 2 patients showed a pathologic PC result. In consequence, 32 patients received the VCE; no CR was observed. Conclusion. Our data indicates that a VCE could safely be performed even if the PC excretion time is longer than 30 hours and the excreted PC was not screened for damage.
背景。对于已知或疑似有胃肠道狭窄风险因素的患者,在进行视频胶囊内镜检查(VCE)之前会给予PillCam通畅胶囊(PC),以尽量降低胶囊滞留(CR)的风险。如果PC在30小时内排出、30小时后以未受损状态排出或通过放射学检查显示进入结肠,则认为不太可能发生CR。方法。我们对2013年2月至2015年4月在奥格斯堡klinikum接受PC的38例有CR风险因素的患者进行了回顾性分析。结果。我们的38例患者中有16例在摄入后平均34小时自然排出。然而,只有8例患者在公司建议的30小时内排出。20例患者通过射频识别扫描或放射学成像显示PC进入结肠(分别在33小时和45小时后)。只有2例患者的PC结果异常。因此,32例患者接受了VCE;未观察到CR。结论。我们的数据表明,即使PC排出时间超过30小时且未对排出的PC进行损伤筛查,也可以安全地进行VCE。